ENZ logo

Enzo Biochem, Inc.

ENZ

ENZ: Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

more

Show ENZ Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of ENZ by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by ENZ's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Sphingosine pathway modulating compounds for the treatment of coronavirus infection Aug. 15, 2023
  • Patent Title: Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor Jun. 06, 2023
  • Patent Title: Antibodies specific for sulfation sites of wnt pathway proteins May. 02, 2023
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of coronavirus infection Jan. 17, 2023
  • Patent Title: Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor beta Nov. 16, 2021
  • Patent Title: Methods for treating bone loss using sclerostin peptides Nov. 09, 2021
  • Patent Title: Affinity tag nucleic acid and protein compositions, and processes for using same Jul. 20, 2021
  • Patent Title: Antibodies specific for sulfation sites of sclerostin Jan. 26, 2021
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of cancers Jan. 05, 2021
  • Patent Title: Monoazo dyes with cyclic amine as fluorescence quenchers Dec. 15, 2020
  • Patent Title: Immunomodulatory pharmaceutical compositions Jul. 14, 2020
  • Patent Title: Methods and intermediates for synthesizing sk1-i Jun. 16, 2020
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of cancers May. 26, 2020
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of cancers May. 12, 2020
  • Patent Title: Diagnosis and treatment of viral diseases Dec. 03, 2019
  • Patent Title: Methods and intermediates for synthesizing sk1-i Jul. 30, 2019
  • Patent Title: Pharmaceutical compositions targeting wnt pathway proteins Jun. 25, 2019
  • Patent Title: Nucleic acid probes for in situ hybridization Jun. 18, 2019
  • Patent Title: Sphingosine pathway modulating compounds for the treatment of cancers May. 07, 2019
  • Patent Title: Immunomodulatory pharmaceutical compositions and methods of use thereof Apr. 02, 2019
  • Patent Title: Affinity tag nucleic acid and protein compositions, and processes for using same Feb. 05, 2019
  • Patent Title: Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids Dec. 04, 2018
  • Patent Title: Monoazo dyes with cyclic amine as fluorescence quencers Nov. 20, 2018
  • Patent Title: Monoazo dyes with cyclic amine as fluorescence quenchers May. 01, 2018
  • Patent Title: Monoazo dyes with cyclic amine as fluorescence quenchers Apr. 24, 2018
  • Patent Title: Diagnosis and treatment of viral diseases Apr. 03, 2018
  • Patent Title: Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications Apr. 03, 2018
  • Patent Title: Compositions and processes for analyte detection, quantification and amplification Jan. 23, 2018
  • Patent Title: Process for detecting or quantifying nucleic acids in a library Oct. 03, 2017
  • Patent Title: Process for detecting or quantifying nucleic acids in a library Sep. 19, 2017
  • Patent Title: Process for detecting or quantifying nucleic acids in a library Aug. 29, 2017
  • Patent Title: Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids May. 16, 2017
  • Patent Title: Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids May. 02, 2017
  • Patent Title: Diagnosis and treatment of viral diseases Apr. 11, 2017
  • Patent Title: Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids Apr. 11, 2017
  • Patent Title: Method for treating crohn's disease or ulcerative colitis by administering a compound which binds ldl-receptor-related protein (lrp) ligand binding domain Nov. 15, 2016
  • Patent Title: Autophagy and phospholipidosis pathway assays Feb. 02, 2016
  • Patent Title: Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications Sep. 15, 2015
  • Patent Title: Compounds and assays for controlling wnt activity Jun. 09, 2015
  • Patent Title: Method for treating inflammation by administering a compound which binds ldl-receptor-related protein (lrp) ligand binding domain Jun. 02, 2015
  • Patent Title: Compositions and methods for bone formation and modeling Mar. 03, 2015
  • Patent Title: Non-ionically bound constructs, and compositions and kits comprising domains Sep. 30, 2014
  • Patent Title: Transmucosal administration of aggregated antigens Jun. 24, 2014
  • Patent Title: Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses Jun. 03, 2014
  • Patent Title: Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses May. 27, 2014
  • Patent Title: Compositions and methods for bone formation and remodeling Jan. 28, 2014
  • Patent Title: Fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest Jan. 29, 2013
  • Patent Title: Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells Jan. 01, 2013
  • Patent Title: Polynucleotides comprising intercalating entities Dec. 18, 2012
  • Patent Title: Selective detection of oncogenic hpv Feb. 28, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of ENZ in WallStreetBets Daily Discussion

ENZ News

Recent insights relating to ENZ

CNBC Recommendations

Recent picks made for ENZ stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ENZ

Corporate Flights

Flights by private jets registered to ENZ